[Meningococcal vaccines: from polysaccharide to conjugate vaccines]. / Vaccins anti-méningococciques: des vaccins polysaccharidiques aux vaccins conjugués.
Arch Pediatr
; 19 Suppl 2: S61-4, 2012 Sep.
Article
em Fr
| MEDLINE
| ID: mdl-22883368
ABSTRACT
Vaccines against the polysaccharide meningococcal capsule lead to the prevention of invasive meningococcal diseases due to serotypes A, C, Y, W135. Polysaccharide vaccines, according to their immunological characteristics, could be used only to protect during a risk period relatively short travel in endemic areas, epidemics and index cases. The dramatic success of the implementation of meningococcal C conjugate vaccines in England, and in several European countries has opened new perspectives. Three ACYW135 conjugate vaccines are or will soon be available. Meningococcal conjugate vaccines may be used for the same indications than polysaccharides vaccines, but also for long term individual protection (both for patient at high risk or without risk factor) and in national immunization programs. They must replace polysaccharide vaccines notably because of the risk of immunologic hypo-responsiveness.
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
2_ODS3
/
4_TD
Base de dados:
MEDLINE
Assunto principal:
Vacinas Meningocócicas
/
Infecções Meningocócicas
/
Neisseria meningitidis
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
Fr
Revista:
Arch Pediatr
Ano de publicação:
2012
Tipo de documento:
Article